Shanghai RAAS Blood Products

Update in progress

002252.SZ (Shenzhen)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Shanghai RAAS Blood Products Co., Ltd., with its subsidiaries, develops and sells plasma-derived and immunoglobulin products in China and internationally. Its range includes ALBURAAS albumin, GAMARAAS intravenous immunoglobulin, HEMORAAS factor VIII, PROTHORAAS prothrombin complex, FIBRORAAS fibrinogen, FIBINGLURAAS fibrin sealant, THROMBIRAAS thrombin, and various immune globulins (specific, tetanus, rabies, hepatitis B) among others. Founded in 1988, based in Shanghai, the company exports worldwide.

Company score

Sentiment: -0.36; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive